By establishing a cutoff value of 100 for normalized CEA mRNA levels, we can distinguish cancer patients from non-cancer patients and, therefore, more confidently consider the expression of CEA mRNA as a marker of circulating tumor cells. The gene discussed is CEACAM5; the disease is neoplasm.